JP4077382B2 - Skin preparation - Google Patents
Skin preparation Download PDFInfo
- Publication number
- JP4077382B2 JP4077382B2 JP2003317786A JP2003317786A JP4077382B2 JP 4077382 B2 JP4077382 B2 JP 4077382B2 JP 2003317786 A JP2003317786 A JP 2003317786A JP 2003317786 A JP2003317786 A JP 2003317786A JP 4077382 B2 JP4077382 B2 JP 4077382B2
- Authority
- JP
- Japan
- Prior art keywords
- added
- extract
- skin
- mixed
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title description 16
- 241000196324 Embryophyta Species 0.000 claims description 27
- 244000169938 Empetrum nigrum Species 0.000 claims description 9
- 235000012778 Empetrum nigrum Nutrition 0.000 claims description 9
- 241000723446 Ceratiola ericoides Species 0.000 claims description 7
- 240000008996 Empetrum rubrum Species 0.000 claims description 4
- 235000000846 Empetrum rubrum Nutrition 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- 239000012071 phase Substances 0.000 description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 210000003491 skin Anatomy 0.000 description 29
- 239000003921 oil Substances 0.000 description 28
- 235000019198 oils Nutrition 0.000 description 28
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 24
- 239000008213 purified water Substances 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 20
- -1 ethylene, propylene, ethane Chemical class 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 18
- 239000007864 aqueous solution Substances 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 15
- 241000208421 Ericaceae Species 0.000 description 13
- 229940058015 1,3-butylene glycol Drugs 0.000 description 12
- 235000019437 butane-1,3-diol Nutrition 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 11
- 238000000605 extraction Methods 0.000 description 11
- 239000008346 aqueous phase Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 230000003020 moisturizing effect Effects 0.000 description 10
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 10
- 229940032094 squalane Drugs 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000021355 Stearic acid Nutrition 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 6
- 239000008117 stearic acid Substances 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000001587 sorbitan monostearate Substances 0.000 description 5
- 235000011076 sorbitan monostearate Nutrition 0.000 description 5
- 229940035048 sorbitan monostearate Drugs 0.000 description 5
- 239000004408 titanium dioxide Substances 0.000 description 5
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 229960000735 docosanol Drugs 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000723447 Ceratiola Species 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000194010 Empetrum Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 244000134552 Plantago ovata Species 0.000 description 2
- 235000003421 Plantago ovata Nutrition 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000009223 Psyllium Substances 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- QNVRIHYSUZMSGM-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229940070687 psyllium Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- NUHVBXMQOSJHOI-UHFFFAOYSA-N 1-aminobutane-2,2-diol Chemical class CCC(O)(O)CN NUHVBXMQOSJHOI-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- TZYRSLHNPKPEFV-UHFFFAOYSA-N 2-ethyl-1-butanol Chemical compound CCC(CC)CO TZYRSLHNPKPEFV-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- BQBYBPAPSIWHCE-UHFFFAOYSA-N 5-(dimethylamino)-2-methylpent-2-enoic acid Chemical compound CN(C)CCC=C(C)C(O)=O BQBYBPAPSIWHCE-UHFFFAOYSA-N 0.000 description 1
- KLDAALHJFPOCLF-UHFFFAOYSA-N 5-(dimethylamino)-2-methylpent-2-enoic acid;1-ethenylpyrrolidin-2-one Chemical compound C=CN1CCCC1=O.CN(C)CCC=C(C)C(O)=O KLDAALHJFPOCLF-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000004246 Agave americana Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 235000003325 Ilex Nutrition 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 244000172533 Viola sororia Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- AFYPFACVUDMOHA-UHFFFAOYSA-N chlorotrifluoromethane Chemical compound FC(F)(F)Cl AFYPFACVUDMOHA-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- KCYQMQGPYWZZNJ-BQYQJAHWSA-N hydron;2-[(e)-oct-1-enyl]butanedioate Chemical compound CCCCCC\C=C\C(C(O)=O)CC(O)=O KCYQMQGPYWZZNJ-BQYQJAHWSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000003915 liquefied petroleum gas Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229960001730 nitrous oxide Drugs 0.000 description 1
- 235000013842 nitrous oxide Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 229940101631 quaternium-18 hectorite Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、保湿効果や肌荒れ改善効果に優れた皮膚外用剤に関する。 The present invention relates to a skin external preparation excellent in a moisturizing effect and a rough skin improving effect.
加齢や疾患による皮膚のバリア機能、水分保持機能の低下や冷暖房等の外的環境による低湿度状態から生じる皮膚の乾燥は、肌荒れを惹き起こす重要な要因となっている。皮膚の乾燥によって生じた肌荒れは、小ジワや皮膚のキメの低下といった皮膚症状を引き起こすだけでなく、痒みや湿疹といった皮膚疾患の原因ともなっている。このため、皮膚の乾燥を防ぎ、肌荒れを防止あるいは改善する保湿剤は、非常に有用性が高いと考えられ、これまで皮膚外用剤の分野では、様々な保湿剤の検索や配合検討がなされてきた。 Skin dryness resulting from low humidity conditions due to external environments such as skin barrier function, moisture retention function, and cooling and heating due to aging and diseases is an important factor that causes rough skin. Rough skin caused by dry skin not only causes skin symptoms such as fine wrinkles and reduced skin texture, but also causes skin diseases such as itching and eczema. For this reason, moisturizers that prevent skin dryness and prevent or improve rough skin are considered to be very useful. So far, in the field of topical skin preparations, various moisturizers have been searched and formulated. It was.
従来の保湿剤としては、グリセリン、ソルビトール、マルチトール、ヒドロキシプロリン、キトサン、ピロリドンカルボン酸ソーダ(非特許文献1参照)が知られている。また、近年では薬用植物をはじめとする植物の抽出物についてもその保湿効果の検討がなされており、ラン科植物(特許文献1参照)、アガベ抽出物(特許文献2参照)、落花生種皮の抽出物(特許文献3参照)、サイリウム抽出物(特許文献4参照)、竜眼種子の抽出物(特許文献5参照)、オオバコ抽出物(特許文献6参照)、キク科ハマグルマ属植物の抽出物(特許文献7参照)、サクラ属植物、スミレ属植物、ノコギリソウ属植物、イトラン属植物、コゴメグサ属植物、モチノキ属植物およびイチョウからなる植物より抽出された各種植物抽出物(特許文献8参照)などが報告されている。 Known humectants include glycerin, sorbitol, maltitol, hydroxyproline, chitosan, and pyrrolidone carboxylate soda (see Non-Patent Document 1). In recent years, the effects of moisturizing the extracts of medicinal plants and other plants have also been studied. Extraction of orchidaceae plants (see Patent Document 1), agave extracts (see Patent Document 2), and peanut seed coats. Extract (see Patent Document 3), psyllium extract (see Patent Document 4), longan seed extract (see Patent Document 5), psyllium extract (see Patent Document 6), extract of the Asteraceae genus Pseudomonas Reference 7), various plant extracts extracted from plants consisting of cherry, violet, yarrow, itlan, italian, ilex and ginkgo (see patent document 8), etc. Has been.
しかし、上記の有効成分を含有する皮膚外用剤はいずれにおいてもその保湿効果、肌荒れ改善効果は必ずしも十分ではなく、より優れた有効成分の開発が求められていた。本発明は、上記事情に鑑みてなされたものであり、その課題は、保湿効果や肌荒れ改善効果に優れた皮膚外用剤を提供することに有る。 However, any of the external preparations for skin containing the above active ingredients is not necessarily sufficient in moisturizing effect and skin roughening improving effect, and development of more effective active ingredients has been demanded. This invention is made | formed in view of the said situation, The subject exists in providing the skin external preparation excellent in the moisturizing effect and the rough skin improvement effect.
本発明者らは、上記課題を解決するために、保湿効果や肌荒れ改善効果に優れた成分を得るべく鋭意研究を重ねた結果、ガンコウラン科(Empetraceae)植物から得られる成分が、保湿効果や肌荒れ改善効果に優れていることを見出し、本発明を完成するに至った。 In order to solve the above-mentioned problems, the present inventors have conducted intensive research to obtain a component excellent in a moisturizing effect and a rough skin improving effect. As a result, a component obtained from a plant of Empetraceae has a moisturizing effect and rough skin. The present inventors have found that the improvement effect is excellent and have completed the present invention.
すなわち、本発明は、ガンコウラン科(Empetraceae)植物から得られる成分を含有することを特徴とする皮膚外用剤を提供するものであり、係る皮膚外用剤は、高い保湿効果並びに高い肌荒れ改善効果を発揮するものである。 That is, the present invention provides a skin external preparation characterized by containing a component obtained from a plant of the family Empetraceae, and the skin external preparation exhibits a high moisturizing effect and a high rough skin improving effect. To do.
本発明の実施の形態を説明する。 An embodiment of the present invention will be described.
ガンコウラン科(Empetraceae)植物は、温帯から寒帯に分布する常緑多年生の草本あるいは小低木で、日本にはガンコウラン属(Empetrum)、ケラティオラ属(Ceratiola)などが知られる。 Gankouran Department (Empetraceae) plant is a herbaceous or small shrubs evergreen perennial distributed in the boreal from temperate, Gankouran genus in Japan (Empetrum), such as Keratiora genus (Ceratiola) is known.
ガンコウラン(Empetrum nigrum Linn. var. japonicum K. Koch)は、北海道、千島、サハリン、シベリア、カムチャッカなどに分布する常緑の小低木で、濃い緑色をした線形の葉がたくさん互生しているガンコウラン属(Empetrum)に属する植物。その実は秋の山の重要な収穫物で、紫黒色の甘酸っぱい実をジャムにしたり焼酎につけて果実酒とする。 Ganko uranium ( Empetrum nigrum Linn. Var. Japonicum K. Koch) is an evergreen small shrub distributed in Hokkaido, Kuril, Sakhalin, Siberia, Kamchatka, etc. Empetrum ). The fruits are an important harvest from the autumn mountain. The purple and black sweet and sour fruits are jammed or shochued into fruit wine.
南アメリカの南部には、果実が赤褐色に熟すエムペトルム・ルブルム(Empetrum rubrum)がみられ、アラスカ州やカナダなどの北半球北部にはエムペトルム・ニグルム(Empetrum nigrum)が広く分布している。エムペトルム・ニグルム(Empetrum nigrum)の地上部は、実とともに煎じてお茶として飲まれている。 In the southern part of South America, there is Empetrum rubrum , where the fruit ripens reddish brown. Empetrum nigrum is widely distributed in the northern northern hemisphere such as Alaska and Canada. The above-ground part of Empetrum nigrum is brewed with tea and drunk as tea.
また、ケラティオラ・エリコイデス(Ceratiola ericoides)は、ケラティオラ属(Ceratiola)に属する植物で、北アメリカ南東部の乾いた林や海岸でみられる。 Ceratiola ericoides is a plant belonging to the genus Ceratiola and is found in dry forests and coasts in southeastern North America.
次に、ガンコウラン科(Empetraceae)植物から成分を得る方法について説明する。上記の植物は、各種の全草又はその葉、幹、茎、枝、枝葉、果皮、果実、樹皮、樹液、種子、根茎、根皮、根、花穂、頭花、花などの1又は2以上の箇所を生のまま若しくは乾燥させて使用する。ガンコウラン科(Empetraceae)植物から成分を得る方法としては、植物体をこのまま用いてもよく、また、圧搾などの処理物を得てもよいし、抽出溶媒を用いて抽出してもよい。抽出溶媒としては特に限定されず、水、エタノール、メタノール、イソプロパノール、イソブタノール、n-ヘキサノール、メチルアミルアルコール、2-エチルブタノール、n-オクチルアルコール等の1価アルコール類、グリセリン、エチレングリコール、エチレングリコールモノメチルエーテル、プロピレングリコール、プロピレングリコールモノメチルエーテル、プロピレングリコールモノエチルエーテル、トリエチレングリコール、1,3-ブチレングリコール、1,2-ペンタンジオール、イソプレングリコール、へキシレングリコール等の多価アルコール又はその誘導体、アセトン、メチルエチルケトン、メチルイソブチルケトン、メチル-n-プロピルケトン等のケトン類、酢酸エチル、酢酸イソプロピル等のエステル類、エチルエーテル、イソプロピルエーテル、n-ブチルエーテル等のエーテル類、スクワラン、ワセリン、パラフィンワックス、パラフィン油などの炭化水素類、オリーブ油、小麦胚芽油、米油、ゴマ油、マカダミアンナッツ油、アルモンド油、ヤシ油等の植物油脂、牛脂、豚脂、鯨油等の動物油脂などが例示される。また、リン酸緩衝生理食塩水等の無機塩類を添加した極性溶媒や界面活性剤を添加した溶媒を用いることもでき、更に、水、二酸化炭素、エチレン、プロピレン、エタン、プロパン、一酸化二窒素、クロロジフルオロメタン、クロロトリフルオロメタン、キセノン、アンモニア、メタノール、エタノールなどの1種又は2種以上の超臨界流体、若しくは亜臨界流体を用いてもよく、特に限定されない。 Next, a method for obtaining a component from an Empetraceae plant will be described. The above plants are one or more of various whole plants or their leaves, stems, stems, branches, branches and leaves, fruit skins, fruits, bark, sap, seeds, rhizomes, root barks, roots, spikes, head flowers, flowers, etc. The part is used raw or dried. As a method for obtaining a component from an Empetraceae plant, the plant body may be used as it is, a processed product such as squeezed may be obtained, or extraction may be performed using an extraction solvent. The extraction solvent is not particularly limited, and monohydric alcohols such as water, ethanol, methanol, isopropanol, isobutanol, n-hexanol, methylamyl alcohol, 2-ethylbutanol, n-octyl alcohol, glycerin, ethylene glycol, ethylene Polyhydric alcohols such as glycol monomethyl ether, propylene glycol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, triethylene glycol, 1,3-butylene glycol, 1,2-pentanediol, isoprene glycol, hexylene glycol or derivatives thereof , Ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, methyl-n-propyl ketone, esters such as ethyl acetate and isopropyl acetate, ethyl ether, Ethers such as pill ether and n-butyl ether, hydrocarbons such as squalane, petrolatum, paraffin wax, paraffin oil, plants such as olive oil, wheat germ oil, rice oil, sesame oil, macadamian nut oil, almond oil, coconut oil Examples include fats and oils such as beef tallow, pork tallow and whale oil. In addition, polar solvents to which inorganic salts such as phosphate buffered saline are added and solvents to which surfactants are added can also be used, and further, water, carbon dioxide, ethylene, propylene, ethane, propane, dinitrogen monoxide. One or more supercritical fluids such as chlorodifluoromethane, chlorotrifluoromethane, xenon, ammonia, methanol, ethanol, etc., or a subcritical fluid may be used without any particular limitation.
抽出の際の植物と溶媒との比率は特に限定されないが、植物1に対して溶媒0.1〜1000重量倍、特に抽出操作、効率の点で、0.5〜100重量倍が好ましい。また抽出温度は0℃から溶媒の沸点以下の範囲とするのが便利であり、抽出時間は抽出温度などにより異なるが1時間〜2週間の範囲とするのが好ましい。 The ratio of the plant and the solvent in the extraction is not particularly limited, but is preferably 0.1 to 1000 times by weight of the solvent with respect to the plant 1, and more preferably 0.5 to 100 times by weight in terms of extraction operation and efficiency. The extraction temperature is conveniently in the range from 0 ° C. to the boiling point of the solvent, and the extraction time is preferably in the range of 1 hour to 2 weeks, although it varies depending on the extraction temperature.
このようにして得られたガンコウラン科(Empetraceae)植物から得られる成分は、各成分をそのまま用いることもできるが、その効果を失わない範囲で、脱臭、脱色、濃縮などの精製操作を加えたり、さらにはカラムクロマトグラフィーなどを用いて分画物として用いてもよい。これらの抽出物や精製物、分画物は、これらから溶媒を除去することによって乾固物とすることもでき、さらに、アルコールなどの溶媒に可溶化した形態、或いは乳剤の形態で用いることができる。 Ingredients obtained from the plant family ( Empetraceae ) thus obtained can be used as they are, but as long as the effect is not lost, purification operations such as deodorization, decolorization and concentration can be added, Furthermore, it may be used as a fraction using column chromatography or the like. These extracts, purified products, and fractions can be dried by removing the solvent from them, and can also be used in a form solubilized in a solvent such as alcohol, or in the form of an emulsion. it can.
本発明では、ガンコウラン科(Empetraceae)植物から得られる成分を皮膚外用剤に配合することにより、優れた皮膚の保湿効果や肌荒れ改善効果を発揮することができる。特に、ガンコウラン(Empetrum nigrum Linn. var. japonicum K. Koch)、エムペトルム・ルブルム(Empetrum rubrum)、エムペトルム・ニグルム(Empetrum nigrum Linn.)、ケラティオラ・エリコイデス(Ceratiola ericoides)がより好適である。 In the present invention, an excellent skin moisturizing effect and rough skin improving effect can be exhibited by blending a component obtained from a plant of Empetraceae with an external preparation for skin. Particularly preferred are gankouran ( Empetrum nigrum Linn. Var. Japonicum K. Koch), Empetrum rubrum , Empetrum nigrum Linn. And Ceratiola ericoides ( Ceratiola ericoides ).
ガンコウラン科(Empetraceae)植物から得られる成分の皮膚外用剤への配合量としては、一般に、0.000001重量%〜10.0重量%であり、好ましくは、0.00001重量%〜5.0重量%、さらに好ましくは0.0001重量%〜1.0重量%である。 The amount of ingredients obtained from the plant of Empetraceae is generally 0.000001 to 10.0% by weight, preferably 0.00001 to 5.0% by weight. %, More preferably 0.0001% by weight to 1.0% by weight.
本発明のガンコウラン科(Empetraceae)植物から得られる成分を皮膚外用剤として使用する場合、クリーム、軟膏、ローション、乳液、固形状、散剤、エアゾールなど任意の剤型とすることができ、化粧水、乳液、美容液、保湿クリーム等の基礎化粧料、日焼け止めクリーム、日焼け止めローション、日焼けオイル、カーマインローション等のサンケア商品、ファンデーション、アイライナー、マスカラ、アイカラー、チークカラー、口紅などのメイクアップ化粧料、洗顔料、ボディーシャンプー、ヘアシャンプー等の洗浄料、リンス、トリートメント、ヘアクリーム、ヘアオイル、整髪剤などの毛髪用化粧料、香水、防臭制汗剤等の形態で提供することができる。 When using the component obtained from the plant of the family Gancolanaceae ( Empetraceae ) of the present invention as an external preparation for skin, it can be in any dosage form such as cream, ointment, lotion, emulsion, solid, powder, aerosol, lotion, Makeup makeup such as basic cosmetics such as milky lotion, beauty serum, moisturizing cream, sun care products such as sun cream, sunscreen lotion, suntan oil, carmine lotion, foundation, eyeliner, mascara, eye color, cheek color, lipstick It can be provided in the form of cosmetics, facial cleansers, body shampoos and hair shampoos, rinses, treatments, hair creams, hair oils, hair cosmetics such as hair styling agents, perfumes and deodorant antiperspirants.
その際、本発明の効果を損なわない範囲内で、皮膚外用剤に一般的に用いられる油性成分、界面活性剤、保湿剤、顔料、紫外線吸収剤、抗酸化剤、香料、防菌防黴剤等の一般的な医薬品及び化粧料用原料や、皮膚細胞賦活剤、抗炎症剤、美白剤等の生理活性成分をも含有させることができる。 At that time, oil components, surfactants, moisturizers, pigments, ultraviolet absorbers, antioxidants, perfumes, antibacterial and antifungal agents generally used for external preparations of the skin within the range not impairing the effects of the present invention And other general pharmaceutical and cosmetic raw materials, and physiologically active ingredients such as skin cell activators, anti-inflammatory agents, and whitening agents.
次に、実施例を挙げて本発明について更に詳細に説明を加えるが、本発明が、これら実施例にのみ限定されないことは言うまでもない。なお、以下に用いる%は、特記しないものはすべて重量%である。 Next, although an Example is given and this invention is demonstrated further in detail, it cannot be overemphasized that this invention is not limited only to these Examples. In addition,% used below is weight% unless otherwise specified.
はじめに、本発明で用いたガンコウラン科(Empetraceae)植物から得られる成分の調製方法を例示する。また、表1に、本発明で用いたガンコウラン科(Empetraceae)植物の具体的な名称と使用部位、更に、それぞれの調製方法で抽出した抽出物1〜抽出物12を記載する。 First, a method for preparing a component obtained from an Empetraceae plant used in the present invention is exemplified. In addition, Table 1 lists the specific names and parts of the Emperaceae plants used in the present invention, and the extracts 1 to 12 extracted by the respective preparation methods.
<調製方法1>
乾燥した植物を、10重量倍量の50容量%エタノール水溶液中にて7日間室温で浸漬した。抽出液をろ過し、減圧下で濃縮及び乾燥を行い、抽出物を得た。
<Preparation method 1>
The dried plant was soaked in a 10% by volume 50% by volume ethanol aqueous solution for 7 days at room temperature. The extract was filtered, concentrated and dried under reduced pressure to obtain an extract.
<調製方法2>
乾燥した植物を、10重量倍量の50容量%1,3−ブチレングリコール水溶液中にて7日間室温で浸漬した。抽出液をろ過し、目的の抽出物を得た。
<Preparation method 2>
The dried plant was immersed in an aqueous solution of 50 volume% 1,3-butylene glycol in an amount of 10 times by weight for 7 days at room temperature. The extract was filtered to obtain the desired extract.
<調製方法3>
乾燥した植物を、超臨界流体抽出装置の抽出槽に投入する。エントレーナとして0.003%のエタノールを加えた後、40℃において15MPaの二酸化炭素を分離槽出口での大気圧下での二酸化炭素の流量が700L/時間となるように調節しながら超臨界状態の二酸化炭素を供給した。その後、抽出槽の圧力を減圧し抽出物を取り出した。
<Preparation method 3>
The dried plant is put into the extraction tank of the supercritical fluid extraction device. After adding 0.003% ethanol as an entrainer, in a supercritical state while adjusting the flow rate of carbon dioxide of 15 MPa at 40 ° C. under atmospheric pressure at the outlet of the separation tank to 700 L / hour. Carbon dioxide was supplied. Then, the pressure of the extraction tank was reduced and the extract was taken out.
そこで、我々は、このガンコウラン科(Empetraceae)植物から得られた成分を皮膚外用剤に配合することを検討した。 Therefore, we examined the incorporation of ingredients obtained from this Empetraceae plant in skin external preparations.
表2に示す処方で処方例1〜処方例4にかかる化粧水を調製した。尚、この化粧水は、(1)に(2)〜(9)を溶解したアルコール相を、(10)〜(12)を均一に混合、溶解した水相に添加して、均一に混合することにより調製した。
The lotions according to Formulation Example 1 to Formulation Example 4 were prepared using the formulation shown in Table 2. In this lotion, the alcohol phase in which (2) to (9) is dissolved in (1) is added to the aqueous phase in which (10) to (12) are uniformly mixed and dissolved, and mixed uniformly. It was prepared by.
本発明の処方例1〜処方例4において、その保湿効果や肌荒れ改善効果について確認すべく、6カ月間の実使用試験を行った。なお、ガンコウラン科(Empetraceae)植物から得られた成分を配合していない処方を比較例とした。実使用試験は、パネラーとして、乾燥肌や肌荒れ症状を顕著に呈する40才〜60才代の女性を1群20名として用い、各群に実施例及び比較例をそれぞれブラインドにて1日2回使用させて行った。使用試験開始前及び終了後に皮膚の状態を観察し、肌状態の改善効果について「改善」、「やや改善」、「変化なし」の3段階にて評価した。結果は、各評価を行ったパネラー数にて表3に示した。 In the prescription examples 1 to 4 of the present invention, an actual use test for 6 months was performed in order to confirm the moisturizing effect and the rough skin improving effect. In addition, the prescription which did not mix | blend the component obtained from the urchinaceae ( Empetraceae ) plant was made into the comparative example. In the practical use test, 40-year-old to 60-year-old women who markedly show dry skin and rough skin symptoms as panelists were used as 20 people per group, and each example and comparative example were blinded twice a day for each group. I was allowed to use it. The skin condition was observed before and after the start of the use test, and the effect of improving the skin condition was evaluated in three stages: “improved”, “slightly improved”, and “no change”. The results are shown in Table 3 in terms of the number of panelists that performed each evaluation.
表3より明らかなように、本発明の処方例1〜処方例4では、全パネラーで症状の改善傾向が見られた。これに対して、ガンコウラン科(Empetraceae)植物から得られる成分を配合していない比較例では、皮膚の乾燥状態及び肌荒れ症状ともに明確な改善傾向が見られたパネラーは存在しなかった。 As is clear from Table 3, in Formulation Example 1 to Formulation Example 4 of the present invention, all the panelists tended to improve symptoms. On the other hand, in the comparative example which did not mix | blend the component obtained from an European family ( Empetraceae ) plant, the paneler in which the clear improvement tendency was seen in the dry state of the skin and the rough skin symptom did not exist.
次に、他の処方例を挙げて本発明を更に詳細に説明するが、本発明はこれらにより何ら限定されるものではない。 Next, the present invention will be described in more detail with reference to other formulation examples, but the present invention is not limited by these.
<処方例5> クレンジングジェル
(1)精製水 残量(重量%)
(2)カーボポール940 0.70
(3)精製水 2.50
(4)1,3−ブチレングリコール 10.00
(5)サリチル酸 0.10
(6)ポリオキシエチレンメチルグルコシド 15.00
(7)ジグリセリン 2.00
(8)モノラウリン酸ポリオキシエチレンソルビット 5.00
(9)モノステアリン酸ソルビタン 2.00
(10)オクテニルコハク酸トウモロコシデンプンエステルアルミニウム 4.00
(11)クエン酸 0.001
(12)精製水 0.009
(13)水酸化ナトリウム 0.20
(14)精製水 1.80
(15)グリチルリチン酸ジカリウム 0.05
(16)精製水 0.45
(17)抽出物1 0.50
製法:80℃に加熱した成分(1)〜(3)に成分(4)〜(10)を加え、ホモミキサーにて撹拌する。50℃まで冷却した後、成分(11)〜(16)を加える。35℃で成分(17)を加え均一化する。
<Prescription Example 5> Cleansing Gel
(1) Remaining purified water (wt%)
(2) Carbopole 940 0.70
(3) Purified water 2.50
(4) 1,3-butylene glycol 10.00
(5) Salicylic acid 0.10
(6) Polyoxyethylene methyl glucoside 15.00
(7) Diglycerin 2.00
(8) Polyoxyethylene sorbit monolaurate 5.00
(9) Sorbitan monostearate 2.00
(10) Octenyl succinic acid corn starch ester aluminum 4.00
(11) Citric acid 0.001
(12) Purified water 0.009
(13) Sodium hydroxide 0.20
(14) Purified water 1.80
(15) Dipotassium glycyrrhizinate 0.05
(16) Purified water 0.45
(17) Extract 1 0.50
Production method: Components (4) to (10) are added to components (1) to (3) heated to 80 ° C., and the mixture is stirred with a homomixer. After cooling to 50 ° C., components (11) to (16) are added. Add ingredient (17) at 35 ° C and homogenize.
<処方例6> O/W乳化型クリーム
(1)スクワラン 10.00(重量%)
(2)ミリスチン酸オクチルドデシル 5.00
(3)水素添加大豆リン脂質 0.20
(4)バチルアルコール 3.00
(5)硬化油 2.00
(6)ステアリン酸 1.50
(7)親油型モノステアリン酸グリセリン 1.50
(8)モノステアリン酸ポリグリセリル 1.50
(9)ベヘニルアルコール 0.80
(10)モノミリスチン酸ポリグリセリル 0.70
(11)サラシミツロウ 0.30
(12)混合脂肪酸トリグリセリド 0.10
(13)d-δ-トコフェロール 0.05
(14)精製水 残量
(15)キサンタンガム(1重量%水溶液) 20.00
(16)1,3-ブチレングリコール 15.00
(17)パラオキシ安息香酸エステル 0.10
(18)水酸化ナトリウム(10重量%水溶液) 2.00
(19)エタノール 2.00
(20)抽出物4 0.30
(21)抽出物7 0.20
製法:(1)〜(13)の油相成分及び(14)〜(17)の水相成分をそれぞれ80℃に加熱し、混合均一化した後、水相に油相を添加する。(18)を加えてホモミキサーにて乳化する。撹拌しながら冷却し、40℃で予め混合、溶解した(19)〜(21)を添加し、撹拌、均一化する。
<Prescription Example 6> O / W emulsified cream
(1) Squalane 10.00 (wt%)
(2) Octyldodecyl myristate 5.00
(3) Hydrogenated soybean phospholipid 0.20
(4) Batyl alcohol 3.00
(5) Hardened oil 2.00
(6) Stearic acid 1.50
(7) Lipophilic glyceryl monostearate 1.50
(8) Polyglyceryl monostearate 1.50
(9) Behenyl alcohol 0.80
(10) Polyglyceryl monomyristate 0.70
(11) Sara beeswax 0.30
(12) Mixed fatty acid triglyceride 0.10
(13) d-δ-tocopherol 0.05
(14) Purified water remaining
(15) Xanthan gum (1 wt% aqueous solution) 20.00
(16) 1,3-butylene glycol 15.00
(17) Paraoxybenzoic acid ester 0.10
(18) Sodium hydroxide (10 wt% aqueous solution) 2.00
(19) Ethanol 2.00
(20) Extract 4 0.30
(21) Extract 7 0.20
Production method: The oil phase components (1) to (13) and the water phase components (14) to (17) are each heated to 80 ° C., mixed and homogenized, and then the oil phase is added to the water phase. Add (18) and emulsify with a homomixer. Cool with stirring, add (19) to (21) previously mixed and dissolved at 40 ° C., and stir and homogenize.
<処方例7> 美容液
(1)ジステアリン酸ポリグリセリル 2.50(重量%)
(2)トリ-2-エチルヘキサン酸グリセリル 8.00
(3)水素添加大豆リン脂質 0.50
(4)モノステアリン酸ソルビタン 0.50
(5)ベヘニルアルコール 0.50
(6)ポリオキシエチレンメチルグルコシド 7.50
(7)精製水 残量
(8)キサンタンガム(1重量%水溶液) 40.00
(9)エタノール 8.00
(10)抽出物5 0.50
製法:(1)〜(5)及び(6)〜(8)の成分をそれぞれ70℃に加熱し混合、溶解した後、両成分を混合してホモミキサーで乳化する。撹拌しながら冷却し、40℃で(9)、(10)の成分を添加し、混合、均一化する。
<Prescription Example 7> Essence
(1) Polyglyceryl distearate 2.50 (% by weight)
(2) Glyceryl tri-2-ethylhexanoate 8.00
(3) Hydrogenated soybean phospholipid 0.50
(4) Sorbitan monostearate 0.50
(5) Behenyl alcohol 0.50
(6) Polyoxyethylene methyl glucoside 7.50
(7) Purified water remaining
(8) Xanthan gum (1 wt% aqueous solution) 40.00
(9) Ethanol 8.00
(10) Extract 5 0.50
Production method: Components (1) to (5) and (6) to (8) are heated to 70 ° C., mixed and dissolved, and then both components are mixed and emulsified with a homomixer. Cool with stirring, add components (9) and (10) at 40 ° C., mix and homogenize.
<処方例8> 化粧水
(1)精製水 残量(重量%)
(2)抽出物10 0.50
(3)抽出物11 0.20
(4)エタノール 8.00
(5)パラオキシ安息香酸エステル 0.05
(6)カルボキシビニルポリマー(1重量%水溶液) 5.00
(7)キサンタンガム(1重量%水溶液) 10.00
(8)1,3−ブチレングリコール 3.00
(9)濃グリセリン 15.00
(10)L−アルギニン 0.10
(11)精製水 0.90
製法:(1)の成分に(2)〜(11)の成分を順次添加して、混合、溶解、均一化する。
<Prescription Example 8> Lotion
(1) Remaining amount of purified water (% by weight)
(2) Extract 10 0.50
(3) Extract 11 0.20
(4) Ethanol 8.00
(5) p-Hydroxybenzoate 0.05
(6) Carboxyvinyl polymer (1 wt% aqueous solution) 5.00
(7) Xanthan gum (1 wt% aqueous solution) 10.00
(8) 1,3-butylene glycol 3.00
(9) Concentrated glycerin 15.00
(10) L-arginine 0.10
(11) Purified water 0.90
Production method: Components (2) to (11) are sequentially added to component (1) to mix, dissolve and homogenize.
<処方例9> クレンジングクリーム
(1)ステアリン酸 2.00(重量%)
(2)セタノール 3.00
(3)ワセリン 10.00
(4)スクワラン 38.00
(5)ミリスチン酸イソプロピル 10.00
(6)酢酸トコフェロール 0.10
(7)グリセリルモノステアリン酸エステル 2.50
(8)モノラウリン酸ポリオキシエチレンソルビット 2.50
(9)プロピレングリコール 5.00
(10)パラオキシ安息香酸メチル 0.10
(11)精製水 残量
(12)水酸化カリウム(10重量%水溶液) 2.00
(13)抽出物3 0.05
製法:(1)〜(8)の油相成分を混合、加熱溶解して70℃とする。一方(9)〜(11)の水相成分を混合、溶解して70℃に加熱する。この水相成分に前記油相成分を徐々に添加した後、(12)を添加しホモミキサーにて均一に乳化する。乳化後、40℃まで冷却した後、(13)を添加し混合する。
<Formulation example 9> Cleansing cream
(1) Stearic acid 2.00 (wt%)
(2) Cetanol 3.00
(3) Vaseline 10.00
(4) Squalane 38.00
(5) Isopropyl myristate 10.00
(6) Tocopherol acetate 0.10
(7) Glyceryl monostearate 2.50
(8) Polyoxyethylene sorbit monolaurate 2.50
(9) Propylene glycol 5.00
(10) Methyl paraoxybenzoate 0.10
(11) Remaining amount of purified water
(12) Potassium hydroxide (10 wt% aqueous solution) 2.00
(13) Extract 3 0.05
Production method: The oil phase components (1) to (8) are mixed and dissolved by heating to 70 ° C. On the other hand, the aqueous phase components (9) to (11) are mixed, dissolved, and heated to 70 ° C. After the oil phase component is gradually added to the water phase component, (12) is added and uniformly emulsified with a homomixer. After emulsification, after cooling to 40 ° C., (13) is added and mixed.
<処方例10> W/O乳化型クリーム
(1)スクワラン 15.00(重量%)
(2)デカメチルシクロペンタシロキサン 15.00
(3)架橋型メチルポリシロキサン 1.00
(4)ジメチコンコポリオール 3.00
(5)クオタニウム-18ヘクトライト 1.00
(6)1,3-ブチレングリコール 8.00
(7)メチルパラベン 0.20
(8)精製水 残量
(9)抽出物6 0.10
製法:(1)〜(5)を混合した油相に、(6)〜(8)の水相を攪拌しながら徐々に添加しホモミキサーにて乳化する。乳化後、(9)を添加し混合する。
<Prescription Example 10> W / O emulsified cream
(1) Squalane 15.00 (wt%)
(2) Decamethylcyclopentasiloxane 15.00
(3) Cross-linked methylpolysiloxane 1.00
(4) Dimethicone copolyol 3.00
(5) quaternium-18 hectorite 1.00
(6) 1,3-butylene glycol 8.00
(7) Methylparaben 0.20
(8) Purified water remaining
(9) Extract 6 0.10
Production method: To the oil phase obtained by mixing (1) to (5), the aqueous phase (6) to (8) is gradually added with stirring and emulsified with a homomixer. After emulsification, (9) is added and mixed.
<処方例11> クレンジングジェル
(1)グリセリン 15.00(重量%)
(2)1,3-ブチレングリコール 10.00
(3)無水ケイ酸 7.00
(4)モノラウリン酸ポリオキシエチレンソルビット 5.00
(5)ポリオキシエチレン(50EO)硬化ヒマシ油 2.50
(6)ジエチレングリコールモノエチルエーテル 5.00
(7)カルボキシビニルポリマー(1重量%水溶液) 50.00
(8)水酸化カリウム(10重量%水溶液) 4.50
(9)抽出物9 0.20
(10)抽出物8 0.50
(11)精製水 残量
製法:(3)、(7)を(11)に添加し均質とした後、(1)及び(2)に(4)〜(6)を溶解させて加え、70℃に加熱して均一に溶解させる。次いで冷却して40℃にて(9)、(10)を添加し、最後に(8)を加えて中和する。
<Prescription Example 11> Cleansing Gel
(1) Glycerin 15.00 (wt%)
(2) 1,3-butylene glycol 10.00
(3) Silicic anhydride 7.00
(4) Monolauric acid polyoxyethylene sorbit 5.00
(5) Polyoxyethylene (50EO) hydrogenated castor oil 2.50
(6) Diethylene glycol monoethyl ether 5.00
(7) Carboxyvinyl polymer (1 wt% aqueous solution) 50.00
(8) Potassium hydroxide (10 wt% aqueous solution) 4.50
(9) Extract 9 0.20
(10) Extract 8 0.50
(11) Purified water Remaining preparation method: (3), (7) is added to (11) and homogenized, (4) to (6) are dissolved and added to (1) and (2). Heat to ℃ to dissolve evenly. Next, the mixture is cooled, (9) and (10) are added at 40 ° C., and finally (8) is added to neutralize.
<処方例12> ヘアリンス
(1)セタノール 3.00(重量%)
(2)塩化ステアリルトリメチルアンモニウム 0.70
(3)シリコーン油 3.00
(4)モノラウリン酸ポリオキシエチレンソルビット 1.00
(5)グリセリン 5.00
(6)緑色3号(1重量%水溶液) 0.20
(7)精製水 残量
(8)抽出物2 0.30
(9)抽出物12 0.05
製法:(7)に(5)、(6)を加え、70℃に加熱する。一方(1)〜(4)を混合、溶解し、70℃に加熱する。この油相を攪拌しながら先に調製した水相に徐々に加えて予備乳化し、ホモミキサーを加えて均一とした後冷却し、40℃にて(8)、(9)を添加する。
<Formulation example 12> Hair rinse
(1) Cetanol 3.00 (wt%)
(2) Stearyltrimethylammonium chloride 0.70
(3) Silicone oil 3.00
(4) Monolauric acid polyoxyethylene sorbit 1.00
(5) Glycerin 5.00
(6) Green No. 3 (1 wt% aqueous solution) 0.20
(7) Purified water remaining
(8) Extract 2 0.30
(9) Extract 12 0.05
Production method: Add (5) and (6) to (7) and heat to 70 ° C. On the other hand, (1) to (4) are mixed and dissolved, and heated to 70 ° C. The oil phase is gradually added to the previously prepared aqueous phase with stirring, pre-emulsified, homogenized with a homomixer, cooled, and (8) and (9) are added at 40 ° C.
<処方例13> ヘアトリートメント
(1)ポリオキシエチレン(30EO)ベへニルエーテル 4.00(重量%)
(2)モノステアリン酸ソルビタン 6.00
(3)ミリスチン酸イソプロピル 5.00
(4)ヘキシルデカノール 5.00
(5)スクワラン 3.00
(6)精製ラノリン 3.00
(7)ステアリン酸 5.00
(8)ラウリルジメチルアミノ酢酸ベタイン 5.00
(9)グリセリン 10.00
(10)精製水 残量
(11)抽出物1 0.50
(12)抽出物4 0.30
(13)抽出物8 0.15
製法:(1)〜(7)の油相成分を混合、加熱して80℃とする。一方、(8)〜(10)の水相成分を混合、加熱して85℃とし、これに前記油相を添加して乳化し、冷却後40℃にて(11)〜(13)を添加する。
<Prescription Example 13> Hair Treatment
(1) Polyoxyethylene (30EO) behenyl ether 4.00 (wt%)
(2) Sorbitan monostearate 6.00
(3) Isopropyl myristate 5.00
(4) Hexyldecanol 5.00
(5) Squalane 3.00
(6) Purified lanolin 3.00
(7) Stearic acid 5.00
(8) Lauryldimethylaminoacetic acid betaine 5.00
(9) Glycerin 10.00
(10) Purified water remaining
(11) Extract 1 0.50
(12) Extract 4 0.30
(13) Extract 8 0.15
Production method: The oil phase components (1) to (7) are mixed and heated to 80 ° C. On the other hand, the water phase components (8) to (10) are mixed and heated to 85 ° C., and the oil phase is added and emulsified, and after cooling, (11) to (13) are added at 40 ° C. To do.
<処方例14> ヘアフォーム
原液処方
(1)モノラウリン酸ポリオキシエチレンソルビット 1.00(重量%)
(2)ジプロピレングリコール 8.00
(3)塩化ステアリルトリメチルアンモニウム 0.10
(4)エタノール 15.00
(5)クエン酸 0.10
(6)抽出物2 0.30
(7)パラオキシ安息香酸エステル 0.10
(8)イソステアロイル加水分解コラーゲン・
アミノメチルプロパンジオール塩 0.10
(9)ビニルピロリドン・
N,N−ジメチルアミノエチルメタクリル酸共重合体 2.00
(10)ポリオキシエチレン・メチルポリシロキサン共重合体 1.00
(11)精製水 残量
充填処方
(a)原液 90.00
(b)噴射剤(液化石油ガス) 10.00
製法:(1)〜(11)を混合し、75℃まで加熱溶解した後、ホモミキサーにて均質に混合する。その後、冷却を行い混合する。充填は、缶に原液を充填し、バルブ装着後ガスを充填する。
<Formulation example 14> Hair foam stock solution formulation
(1) Polyoxyethylene sorbit monolaurate 1.00 (wt%)
(2) Dipropylene glycol 8.00
(3) Stearyltrimethylammonium chloride 0.10
(4) Ethanol 15.00
(5) Citric acid 0.10
(6) Extract 2 0.30
(7) Paraoxybenzoic acid ester 0.10
(8) Isostearoyl hydrolyzed collagen
Aminomethylpropanediol salt 0.10
(9) Vinylpyrrolidone
N, N-dimethylaminoethyl methacrylic acid copolymer 2.00
(10) Polyoxyethylene / methylpolysiloxane copolymer 1.00
(11) Refining water
(a) Stock solution 90.00
(b) Propellant (liquefied petroleum gas) 10.00
Production method: (1) to (11) are mixed, dissolved by heating to 75 ° C, and then homogeneously mixed with a homomixer. Then, it cools and mixes. For filling, the stock solution is filled into a can, and gas is filled after the valve is mounted.
<処方例15> ヘアワックス
(1)キャンデリラロウ 4.00(重量%)
(2)ベヘニルアルコール 1.00
(3)流動パラフィン 20.00
(4)スクワラン 10.00
(5)モノラウリン酸ポリオキシエチレンソルビット 3.00
(6)抽出物6 0.30
(7)高重合ポリエチレングリコール 0.10
(8)オキシベンゾン 0.05
(9)ビニルピロリドン・N,N−ジメチルアミノエチル
メタクリル酸共重合体ジエチル硫酸塩液 1.00
(10)キサンタンガム 0.10
(11)カルボキシビニルポリマー 0.05
(12)ヒドロキシプロピルメチルセルロース 0.20
(13)プロピレングリコール 10.00
(14)2−アミノ−2−メチル−1−プロパノール 0.10
(15)精製水 残量
(16)加水分解シルク 0.10
製法:(1)〜(9)を混合溶解して油相とする。一方、(10)〜(14)を(15)に添加し、溶解して水相とする。次いで、75℃にて水相に油相を添加し、ホモミキサーにて均一に乳化する。その後冷却を行い、40℃で(16)を添加し混合する。
<Prescription Example 15> Hair wax
(1) Candelilla wax 4.00 (wt%)
(2) Behenyl alcohol 1.00
(3) Liquid paraffin 20.00
(4) Squalane 10.00
(5) Polyoxyethylene sorbit monolaurate 3.00
(6) Extract 6 0.30
(7) Highly polymerized polyethylene glycol 0.10
(8) Oxybenzone 0.05
(9) Vinylpyrrolidone / N, N-dimethylaminoethyl methacrylic acid copolymer diethyl sulfate solution 1.00
(10) Xanthan gum 0.10
(11) Carboxyvinyl polymer 0.05
(12) Hydroxypropyl methylcellulose 0.20
(13) Propylene glycol 10.00
(14) 2-Amino-2-methyl-1-propanol 0.10
(15) Purified water remaining
(16) Hydrolyzed silk 0.10
Production method: (1) to (9) are mixed and dissolved to obtain an oil phase. On the other hand, (10) to (14) are added to (15) and dissolved to form an aqueous phase. Next, the oil phase is added to the aqueous phase at 75 ° C., and the mixture is uniformly emulsified with a homomixer. Thereafter, cooling is performed, and (16) is added and mixed at 40 ° C.
<処方例16> ヘアジェル
(1)精製水 残量(重量%)
(2)カルボキシビニルポリマー 0.70
(3)N−メタクリロイルオキシエチルN,N−ジメチルアンモニウム−α
−N−メチルカルボキシベタイン・メタクリル酸アルキルエステル共重合体
5.00
(4)ポリオキシエチレンメチルグルコシド 5.00
(5)エタノール 10.00
(6)モノラウリン酸ポリオキシエチレンソルビット 1.50
(7)抽出物11 0.60
(8)エデト酸三ナトリウム 0.05
(9)水酸化ナトリウム(10重量%水溶液) 0.50
製法:(1)に(2)及び(3)を溶解する。次いで(4)〜(8)を順次添加し均一化した後、(9)を添加して中和する。
<Prescription Example 16> Hair Gel
(1) Remaining amount of purified water (% by weight)
(2) Carboxyvinyl polymer 0.70
(3) N-methacryloyloxyethyl N, N-dimethylammonium-α
-N-methylcarboxybetaine / alkyl methacrylate ester copolymer
5.00
(4) Polyoxyethylene methyl glucoside 5.00
(5) Ethanol 10.00
(6) Polyoxyethylene sorbit monolaurate 1.50
(7) Extract 11 0.60
(8) edetate trisodium 0.05
(9) Sodium hydroxide (10 wt% aqueous solution) 0.50
Production method: (2) and (3) are dissolved in (1). Next, (4) to (8) are sequentially added and homogenized, and then (9) is added to neutralize.
<処方例17> トニック
(1)エタノール 60.00(重量%)
(2)L−メントール 0.30
(3)パラオキシ安息香酸エステル 0.05
(4)トウガラシチンキ 0.70
(5)抽出物7 0.50
(6)ポリオキシエチレン硬化ヒマシ油 0.20
(7)ポリオキシエチレンメチルグルコシド 1.50
(8)精製水 残量
製法:(1)〜(5)のアルコール相を混合し、均一化しておく。50℃で溶解した成分(6)にアルコール相を加え、予め均一化しておいた成分(7)と(8)を加えて混合した後、ろ過する。
<Prescription Example 17> Tonic
(1) Ethanol 60.00 (wt%)
(2) L-Menthol 0.30
(3) Paraoxybenzoic acid ester 0.05
(4) Pepper tincture 0.70
(5) Extract 7 0.50
(6) Polyoxyethylene hydrogenated castor oil 0.20
(7) Polyoxyethylene methyl glucoside 1.50
(8) Purified water Remaining production method: The alcohol phases (1) to (5) are mixed and homogenized. The alcohol phase is added to component (6) dissolved at 50 ° C., components (7) and (8) that have been homogenized in advance are added and mixed, and then filtered.
<処方例18> 洗顔料
(1)ステアリン酸 10.00(重量%)
(2)パルミチン酸 10.00
(3)ミリスチン酸 12.00
(4)ラウリン酸 4.00
(5)オレイルアルコール 1.50
(6)ラノリンアルコール 1.00
(7)水酸化カリウム 6.00
(8)精製水 残量
(9)1,3-ブチレングリコール 10.00
(10)抽出物5 0.30
(11)抽出物3 0.05
(12)抽出物10 0.30
製法:(1)〜(6)の油相及び(7)〜(9)の水相をそれぞれ75℃に混合加熱溶解した後、油相に水相を加えてケン化する。冷却後40℃で(10)〜(12)を添加して混合する。
<Prescription Example 18> Face wash
(1) Stearic acid 10.00 (wt%)
(2) Palmitic acid 10.00
(3) Myristic acid 12.00
(4) Lauric acid 4.00
(5) Oleyl alcohol 1.50
(6) Lanolin alcohol 1.00
(7) Potassium hydroxide 6.00
(8) Purified water remaining
(9) 1,3-butylene glycol 10.00
(10) Extract 5 0.30
(11) Extract 3 0.05
(12) Extract 10 0.30
Production method: The oil phases (1) to (6) and the water phases (7) to (9) are mixed and dissolved at 75 ° C., respectively, and then the water phase is added to the oil phase to saponify. After cooling, add (10) to (12) at 40 ° C. and mix.
<処方例19> ボディシャンプー
(1)ラウリン酸 5.00(重量%)
(2)ミリスチン酸 7.50
(3)ラウロイルジエタノールアミド 5.00
(4)1,3-ブチレングリコール 10.00
(5)グリセリン 10.00
(6)水酸化カリウム(10重量%水溶液) 3.00
(7)精製水 残量
(8)抽出物9 0.10
製法:(1)〜(3)の油相及び(4)〜(7)の水相をそれぞれ75℃に混合加熱溶解した後、油相に水相を加えてケン化する。冷却後40℃で(8)を添加して混合する。
<Prescription example 19> Body shampoo
(1) Lauric acid 5.00 (wt%)
(2) Myristic acid 7.50
(3) Lauroyl diethanolamide 5.00
(4) 1,3-butylene glycol 10.00
(5) Glycerin 10.00
(6) Potassium hydroxide (10 wt% aqueous solution) 3.00
(7) Purified water remaining
(8) Extract 9 0.10
Production method: The oil phases (1) to (3) and the water phases (4) to (7) are mixed and dissolved at 75 ° C., respectively, and then the water phase is added to the oil phase to saponify. After cooling, add (8) at 40 ° C. and mix.
<処方例20> メイクアップベース
(1)ステアリン酸 1.00(重量%)
(2)ベヘニルアルコール 0.50
(3)モノステアリン酸ソルビタン 1.50
(4)スクワラン 10.00
(5)1,3-ブチレングリコール 10.00
(6)グリセリン 3.00
(7)精製水 残量
(8)キサンタンガム(1重量%水溶液) 10.00
(9)水酸化カリウム(10重量%水溶液) 1.00
(10)抽出物12 0.20
(11)二酸化チタン 1.00
(12)ベンガラ 0.01
(13)黄酸化鉄 0.04
製法:(11)〜(13)を(5)で混練し、これを(6)〜(8)の水相に添加、混合し、70℃に加熱する。一方、(1)〜(4)の油相成分を混合、加熱して70℃とする。(9)を加えた水相に油相を攪拌しながら添加して乳化する。40℃まで冷却した後、(10)を添加する。
<Prescription Example 20> Makeup Base
(1) Stearic acid 1.00 (wt%)
(2) Behenyl alcohol 0.50
(3) Sorbitan monostearate 1.50
(4) Squalane 10.00
(5) 1,3-butylene glycol 10.00
(6) Glycerin 3.00
(7) Purified water remaining
(8) Xanthan gum (1 wt% aqueous solution) 10.00
(9) Potassium hydroxide (10 wt% aqueous solution) 1.00
(10) Extract 12 0.20
(11) Titanium dioxide 1.00
(12) Bengala 0.01
(13) Yellow iron oxide 0.04
Production method: (11) to (13) are kneaded in (5), added to the aqueous phases (6) to (8), mixed, and heated to 70 ° C. On the other hand, the oil phase components (1) to (4) are mixed and heated to 70 ° C. The oil phase is added to the aqueous phase to which (9) has been added while stirring to emulsify. After cooling to 40 ° C., (10) is added.
<処方例21> O/W乳化型ファンデーション
(1)ステアリン酸 1.00(重量%)
(2)スクワラン 5.00
(3)ミリスチン酸オクチルドデシル 5.00
(4)セタノール 1.00
(5)自己乳化型グリセリルモノステアリン酸エステル 1.50
(6)1,3-ブチレングリコール 8.00
(7)キサンタンガム(1重量%水溶液) 10.00
(8)精製水 残量
(9)水酸化カリウム(10重量%水溶液) 1.00
(10)酸化チタン 9.00
(11)タルク 7.40
(12)ベンガラ 0.50
(13)黄酸化鉄 1.50
(14)黒酸化鉄 0.20
(15)抽出物1 0.50
製法:(10)〜(14)を(6)で混練し、これを(7)、(8)の水相に添加、混合し、70℃に加熱する。一方、(1)〜(5)の油相成分を混合、加熱して70℃とする。(9)を加えた水相に油相を攪拌しながら添加して乳化する。40℃まで冷却した後、(15)を添加する。
<Prescription Example 21> O / W emulsified foundation
(1) Stearic acid 1.00 (wt%)
(2) Squalane 5.00
(3) Octyl dodecyl myristate 5.00
(4) Cetanol 1.00
(5) Self-emulsifying glyceryl monostearate 1.50
(6) 1,3-butylene glycol 8.00
(7) Xanthan gum (1 wt% aqueous solution) 10.00
(8) Purified water remaining
(9) Potassium hydroxide (10 wt% aqueous solution) 1.00
(10) Titanium oxide 9.00
(11) Talc 7.40
(12) Bengala 0.50
(13) Yellow iron oxide 1.50
(14) Black iron oxide 0.20
(15) Extract 1 0.50
Production method: (10) to (14) are kneaded in (6), added to the aqueous phases (7) and (8), mixed, and heated to 70 ° C. On the other hand, the oil phase components (1) to (5) are mixed and heated to 70 ° C. The oil phase is added to the aqueous phase to which (9) has been added while stirring to emulsify. After cooling to 40 ° C., (15) is added.
<処方例22> W/O乳化型ファンデーション
(1)タルク 10.00(重量%)
(2)微粒子二酸化チタン 5.00
(3)二酸化チタン 8.00
(4)ポリアクリル酸アルキル 5.00
(5)ベンガラ 0.40
(6)黄酸化鉄 1.50
(7)黒酸化鉄 0.20
(8)スクワラン 7.00
(9)デカメチルシクロペンタシロキサン 10.00
(10)ポリオキシエチレン変性ジメチルポリシロキサン 4.00
(11)パラメトキシ桂皮酸オクチル 3.00
(12)精製水 残量
(13)1,3-ブチレングリコール 5.00
(14)パラオキシ安息香酸メチル 0.20
(15)抽出物4 0.70
製法:(8)〜(11)の油相成分を均一に混合し、(1)〜(7)を添加してホモミキサーで分散させ油相分散液を調製する。加熱溶解した(12)〜(14)を油相分散液に添加し乳化する。最後に(15)を添加して均一に混合する。
<Prescription Example 22> W / O emulsified foundation
(1) Talc 10.00 (wt%)
(2) Fine particle titanium dioxide 5.00
(3) Titanium dioxide 8.00
(4) Alkyl polyacrylate 5.00
(5) Bengala 0.40
(6) Yellow iron oxide 1.50
(7) Black iron oxide 0.20
(8) Squalane 7.00
(9) Decamethylcyclopentasiloxane 10.00
(10) Polyoxyethylene-modified dimethylpolysiloxane 4.00
(11) Octyl paramethoxycinnamate 3.00
(12) Remaining amount of purified water
(13) 1,3-Butylene glycol 5.00
(14) Methyl paraoxybenzoate 0.20
(15) Extract 4 0.70
Production method: Oil phase components (8) to (11) are uniformly mixed, (1) to (7) are added and dispersed with a homomixer to prepare an oil phase dispersion. Heat-dissolved (12) to (14) are added to the oil phase dispersion and emulsified. Finally add (15) and mix uniformly.
<処方例23> ツーウェイファンデーション
(1)シリコーン処理タルク 残量(重量%)
(2)シリコーン処理マイカ 20.00
(3)シリコーン処理二酸化チタン 10.00
(4)シリコーン処理微粒子二酸化チタン 2.00
(5)フッ素処理ベンガラ 0.45
(6)フッ素処理黄酸化鉄 2.20
(7)フッ素処理黒酸化鉄 0.22
(8)ステアリン酸亜鉛 1.00
(9)ナイロンパウダー 5.00
(10)スクワラン 5.00
(11)モノステアリン酸ソルビタン 0.10
(12)ジメチルポリシロキサン 4.00
(13)リンゴ酸ジイソステアリル 1.00
(14)パラメトキシケイ皮酸オクチル 2.00
(15)酢酸トコフェロール 0.05
(16)抽出物3 0.02
製法:(1)〜(9)の粉体相をハンマーミルで粉砕した後、ブレンダーで混合し均一化する。(10)〜(16)の油相を80℃で溶解し均一化した後、粉体相に添加して混練する。その後、ハンマーミルで粉砕し、篩過したバルクを金皿に圧縮成型する。
<Prescription Example 23> Two-way Foundation
(1) Silicone-treated talc Remaining amount (wt%)
(2) Silicone-treated mica 20.00
(3) Silicone-treated titanium dioxide 10.00
(4) Silicone-treated fine particle titanium dioxide 2.00
(5) Fluorine-treated Bengala 0.45
(6) Fluorine-treated yellow iron oxide 2.20
(7) Fluorine-treated black iron oxide 0.22
(8) Zinc stearate 1.00
(9) Nylon powder 5.00
(10) Squalane 5.00
(11) Sorbitan monostearate 0.10
(12) Dimethylpolysiloxane 4.00
(13) Diisostearyl malate 1.00
(14) Octyl paramethoxycinnamate 2.00
(15) Tocopherol acetate 0.05
(16) Extract 3 0.02
Production method: After the powder phases (1) to (9) are pulverized with a hammer mill, they are mixed and homogenized with a blender. The oil phases (10) to (16) are dissolved and homogenized at 80 ° C., and then added to the powder phase and kneaded. Then, it grind | pulverizes with a hammer mill and the bulk sifted is compression-molded to a metal plate.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003317786A JP4077382B2 (en) | 2003-09-10 | 2003-09-10 | Skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003317786A JP4077382B2 (en) | 2003-09-10 | 2003-09-10 | Skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005082543A JP2005082543A (en) | 2005-03-31 |
JP4077382B2 true JP4077382B2 (en) | 2008-04-16 |
Family
ID=34417240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003317786A Expired - Lifetime JP4077382B2 (en) | 2003-09-10 | 2003-09-10 | Skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4077382B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109966211A (en) * | 2019-05-05 | 2019-07-05 | 上海悦目化妆品有限公司 | A kind of fresh extraction technology of plant and its application in cosmetic mask |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100863614B1 (en) * | 2007-04-16 | 2008-10-15 | 바이오스펙트럼 주식회사 | Compositions for improving skin conditions comprising crowberry extract |
JP2016088872A (en) * | 2014-10-31 | 2016-05-23 | 株式会社コスモステクニカルセンター | TEXTURE IMPROVING AGENT IN WHICH α GEL-STRUCTURE IS FORMED, AND COSMETIC OR EXTERNAL SKIN PREPARATION FOR IMPROVING TEXTURE CONTAINING THE SAME |
-
2003
- 2003-09-10 JP JP2003317786A patent/JP4077382B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109966211A (en) * | 2019-05-05 | 2019-07-05 | 上海悦目化妆品有限公司 | A kind of fresh extraction technology of plant and its application in cosmetic mask |
Also Published As
Publication number | Publication date |
---|---|
JP2005082543A (en) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3583108B2 (en) | External preparation for skin | |
JP4685374B2 (en) | Topical skin preparation | |
JP5557414B2 (en) | Moisturizer, cell activator, and whitening agent | |
JP2003104865A (en) | Skin care preparation | |
JP4077382B2 (en) | Skin preparation | |
JP4045160B2 (en) | Skin preparation | |
JP4004444B2 (en) | Topical skin preparation | |
JP3597520B2 (en) | External preparation for skin | |
JP2004123657A (en) | External preparation for skin | |
JP5795146B2 (en) | Moisturizer and external preparation for skin | |
JP2011046646A (en) | Antioxidant and skin external preparation | |
JP2003342118A (en) | Skin care preparation | |
JP3658379B2 (en) | Topical skin preparation | |
JP3754025B2 (en) | Cell activator, antioxidant, and skin external preparation | |
JP3491755B1 (en) | External preparation for skin | |
JP2004352628A (en) | External preparation for skin | |
JP3605693B2 (en) | External preparation for skin | |
JP4748962B2 (en) | Moisturizer, cell activator, whitening agent, and antioxidant | |
JP5455634B2 (en) | Skin preparations and moisturizers | |
JP5116428B2 (en) | Moisturizer and external preparation for skin | |
JP2009057309A (en) | Skin preparation for external use and humectant | |
JP2003267851A (en) | Skin care preparation | |
JP2003313107A (en) | Cosmetic composition comprising ginseng saponins | |
JP3658383B2 (en) | Topical skin preparation | |
JP4515423B2 (en) | Moisturizer, cell activator, and antioxidant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060821 |
|
RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20060821 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20070626 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20070723 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070817 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071011 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20071011 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080129 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080131 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4077382 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110208 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120208 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120208 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130208 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140208 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |